NCT03220633View on ClinicalTrials.gov

Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Chronic Pain
Interventions
DRUG

ATB-346

DRUG

Placebo

Trial Locations (1)

Unknown

Algorithme Pharma, Montreal

Sponsors

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Antibe Therapeutics Inc.

INDUSTRY